These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

169 related items for PubMed ID: 11395975

  • 1. The role of antiviral and immunoglobulin therapy in the prevention of Epstein-Barr virus infection and post-transplant lymphoproliferative disease following solid organ transplantation.
    Green M, Reyes J, Webber S, Rowe D.
    Transpl Infect Dis; 2001 Jun; 3(2):97-103. PubMed ID: 11395975
    [Abstract] [Full Text] [Related]

  • 2. [Prophylaxis against Epstein Barr disease in pediatric and adult patients undergoing solid organ and hematopoietic stem cells transplantation].
    Catalán P, Alba A.
    Rev Chilena Infectol; 2012 Sep; 29 Suppl 1():S29-31. PubMed ID: 23282553
    [Abstract] [Full Text] [Related]

  • 3. A randomized trial of ganciclovir versus ganciclovir plus immune globulin for prophylaxis against Epstein-Barr virus related posttransplant lymphoproliferative disorder.
    Humar A, Hébert D, Davies HD, Humar A, Stephens D, O'Doherty B, Allen U.
    Transplantation; 2006 Mar 27; 81(6):856-61. PubMed ID: 16570008
    [Abstract] [Full Text] [Related]

  • 4. Antiviral prophylaxis and the Epstein Barr virus-related post-transplant lymphoproliferative disorder.
    Davis CL, Harrison KL, McVicar JP, Forg PJ, Bronner MP, Marsh CL.
    Clin Transplant; 1995 Feb 27; 9(1):53-9. PubMed ID: 7742583
    [Abstract] [Full Text] [Related]

  • 5. Epstein-Barr virus-related post-transplant lymphoproliferative disorder in solid organ transplant recipients.
    San-Juan R, Comoli P, Caillard S, Moulin B, Hirsch HH, Meylan P, ESCMID Study Group of Infection in Compromised Hosts.
    Clin Microbiol Infect; 2014 Sep 27; 20 Suppl 7():109-18. PubMed ID: 24475976
    [Abstract] [Full Text] [Related]

  • 6. The Role of Antiviral Prophylaxis for the Prevention of Epstein-Barr Virus-Associated Posttransplant Lymphoproliferative Disease in Solid Organ Transplant Recipients: A Systematic Review.
    AlDabbagh MA, Gitman MR, Kumar D, Humar A, Rotstein C, Husain S.
    Am J Transplant; 2017 Mar 27; 17(3):770-781. PubMed ID: 27545492
    [Abstract] [Full Text] [Related]

  • 7. Epstein-Barr virus: evasive maneuvers in the development of PTLD.
    Snow AL, Martinez OM.
    Am J Transplant; 2007 Feb 27; 7(2):271-7. PubMed ID: 17229074
    [Abstract] [Full Text] [Related]

  • 8. The Changing Epidemiology of Posttransplant Lymphoproliferative Disorder in Adult Solid Organ Transplant Recipients Over 30 Years: A Single-center Experience.
    Peters AC, Akinwumi MS, Cervera C, Mabilangan C, Ghosh S, Lai R, Iafolla M, Doucette K, Preiksaitis JK.
    Transplantation; 2018 Sep 27; 102(9):1553-1562. PubMed ID: 29485513
    [Abstract] [Full Text] [Related]

  • 9. Impact of antiviral prophylaxis in adults Epstein-Barr Virus-seronegative kidney recipients on early and late post-transplantation lymphoproliferative disorder onset: a retrospective cohort study.
    Ville S, Imbert-Marcille BM, Coste-Burel M, Garandeau C, Meurette A, Cantarovitch D, Giral M, Hourmant M, Blancho G, Dantal J.
    Transpl Int; 2018 May 27; 31(5):484-494. PubMed ID: 29057508
    [Abstract] [Full Text] [Related]

  • 10. Epstein-Barr virus encephalitis in solid organ transplantation.
    Lau JSY, Low ZM, Abbott I, Shochet L, Kanellis J, Kitching AR, Korman TM.
    New Microbiol; 2017 Jul 27; 40(3):212-217. PubMed ID: 28513810
    [Abstract] [Full Text] [Related]

  • 11. Management of post-transplant Epstein-Barr virus-related lymphoproliferative disease in solid organ and hematopoietic stem cell recipients.
    Marques HH, Shikanai-Yasuda MA, dAzevedo LS, Caiaffa-Filho HH, Pierrotti LC, Aquino MZ, Lopes MH, Maluf NZ, Campos SV, Costa SF.
    Rev Soc Bras Med Trop; 2014 Jul 27; 47(5):543-6. PubMed ID: 25467252
    [Abstract] [Full Text] [Related]

  • 12. The management of Epstein-Barr virus associated post-transplant lymphoproliferative disorders in pediatric solid-organ transplant recipients.
    Green M, Michaels MG, Webber SA, Rowe D, Reyes J.
    Pediatr Transplant; 1999 Nov 27; 3(4):271-81. PubMed ID: 10562971
    [Abstract] [Full Text] [Related]

  • 13. The antiviral prophylaxis of post-transplant lymphoproliferative disorder.
    Davis CL.
    Springer Semin Immunopathol; 1998 Nov 27; 20(3-4):437-53. PubMed ID: 9870256
    [No Abstract] [Full Text] [Related]

  • 14. Prospective Epstein-Barr virus-related post-transplant lymphoproliferative disorder prevention program in pediatric allogeneic hematopoietic stem cell transplant: virological monitoring and first-line treatment.
    Chiereghin A, Prete A, Belotti T, Gibertoni D, Piccirilli G, Gabrielli L, Pession A, Lazzarotto T.
    Transpl Infect Dis; 2016 Feb 27; 18(1):44-54. PubMed ID: 26574232
    [Abstract] [Full Text] [Related]

  • 15. A Focused Review of Epstein-Barr Virus Infections and PTLD in Pediatric Transplant Recipients: Guidance From the IPTA and ECIL Guidelines.
    Yamada M, L'Huillier AG, Green M.
    J Pediatric Infect Dis Soc; 2024 Feb 28; 13(Supplement_1):S31-S38. PubMed ID: 38417085
    [Abstract] [Full Text] [Related]

  • 16. Management of Epstein-Barr virus-induced post-transplant lymphoproliferative disease in recipients of solid organ transplantation.
    Green M.
    Am J Transplant; 2001 Jul 28; 1(2):103-8. PubMed ID: 12099356
    [Abstract] [Full Text] [Related]

  • 17. Anti-viral prophylaxis reduces the incidence of lymphoproliferative disease in lung transplant recipients.
    Malouf MA, Chhajed PN, Hopkins P, Plit M, Turner J, Glanville AR.
    J Heart Lung Transplant; 2002 May 28; 21(5):547-54. PubMed ID: 11983544
    [Abstract] [Full Text] [Related]

  • 18. The biology of Epstein-Barr virus in post-transplant lymphoproliferative disease.
    Hsieh WS, Lemas MV, Ambinder RF.
    Transpl Infect Dis; 1999 Sep 28; 1(3):204-12. PubMed ID: 11428990
    [Abstract] [Full Text] [Related]

  • 19. Complete immunosuppressive withdrawal as a uniform approach to post-transplant lymphoproliferative disease in pediatric liver transplantation.
    Hurwitz M, Desai DM, Cox KL, Berquist WE, Esquivel CO, Millan MT.
    Pediatr Transplant; 2004 Jun 28; 8(3):267-72. PubMed ID: 15176965
    [Abstract] [Full Text] [Related]

  • 20. Current preventive strategies and management of Epstein-Barr virus-related post-transplant lymphoproliferative disease in solid organ transplantation in Europe. Results of the ESGICH Questionnaire-based Cross-sectional Survey.
    San-Juan R, Manuel O, Hirsch HH, Fernández-Ruiz M, López-Medrano F, Comoli P, Caillard S, Grossi P, Aguado JM, ESGICH PTLD Survey Study Group,, European Study Group of Infections in Compromised Hosts (ESGICH) from the European Society of Microbiology and Infectious Diseases (ESCMID).
    Clin Microbiol Infect; 2015 Jun 28; 21(6):604.e1-9. PubMed ID: 25686696
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.